Assertio Therapeutics, Inc. buy PlusUltra
Start price
13.03.20
/
50%
€0.71
Target price
22.05.20
€3.00
Performance (%)
2.13%
End price
22.05.20
-
Summary
This prediction ended on 22.05.20 with a price of -. With a performance of 2.13%, the BUY prediction by PlusUltra for Assertio Therapeutics, Inc. closed with a slight gain. PlusUltra has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
Comments by PlusUltra for this prediction
In the thread Discuss Assertio Therapeutics, Inc.
Buy with target price 3.0